Who
Enrique Poradosu
Chief Science & Business Off
Company insider
Files Form 4 as: Chief Science & Business Off, Nuvectis Pharma.
In numbers
- Trades disclosed
- 13
- Buys
- 6
- Sells
- 0
- Bought
- $45K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Feb 2022
- Last trade
- 6 Jan 2026
- Last filed
- 9 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jan 2026filed 9 Jan 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 6 Jan 2026filed 9 Jan 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 19 Nov 2024filed 20 Nov 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $9,9802,000 at $4.99 | filing |
| 10 May 2024filed 13 May 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $3,145500 at $6.29 | filing |
| 3 Jan 2024filed 5 Jan 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 27 Mar 2023filed 28 Mar 2023 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $5,775500 at $11.55 | filing |
| 12 Jan 2023filed 13 Jan 2023 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 12 May 2022filed 16 May 2022 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $5,461370 at $14.76 | filing |
| 12 May 2022filed 16 May 2022 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $4,812300 at $16.04 | filing |
| 1 Apr 2022filed 5 Apr 2022 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 7 Feb 2022filed 8 Feb 2022 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $3,104800 at $3.88 | filing |
| 4 Feb 2022filed 8 Feb 2022 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $13K3,800 at $3.35 | filing |
News
Nuvectis Pharma (NASDAQ:NVCT) Stock Falls 6.8% – Here's WhyNVCT · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Enrique Poradosu; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.